Treatment of diabetic retinopathy through neuropeptide Y‐mediated enhancement of neurovascular microenvironment

Diabetic retinopathy (DR) is one of the most severe clinical manifestations of diabetes mellitus and a major cause of blindness. DR is principally a microvascular disease, although the pathogenesis also involves metabolic reactive intermediates which induce neuronal and glial activation resulting in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Kepeng, Copland, David A., Theodoropoulou, Sofia, Mertsch, Sonja, Li, Youjian, Liu, Jian, Schrader, Stefan, Liu, Lei, Dick, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171318/
https://www.ncbi.nlm.nih.gov/pubmed/32141716
http://dx.doi.org/10.1111/jcmm.15016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171318/
https://www.ncbi.nlm.nih.gov/pubmed/32141716
http://dx.doi.org/10.1111/jcmm.15016

Ejemplares similares